Alex Belov
Developers by oneinveststock.com. Analyst, investor
Salesforce (CRM) Stock Price Today, Real-Time Quotes, Forecasts
Salesforce (CRM) Stock: Real Time Chart and Quotes
Stock Consensus Rating = "Neutral"
Lowest Price Target
$119.00
Average target price
$159.00
Maximum target price
$236.00
Salesforce
CRM
Stock = Salesforce
ISIN = US79466L3024
About company = The developer of the CRM-system of the same name, which is distributed for customers according to the SaaS model. The Salesforce ecosystem includes Force, which provides a PaaS system for self-developers. And the Database brand offers a cloud-based database management system.
Salesforce (CRM) Stock Forecasts, Predictions
On January 30, 2023 analytical firm “Morgan Stanley” published a latest price target for Salesforce Inc (CRM) stock of $236,00 for the next 12 months. 97 analyst firms have released forecasts for Salesforce Inc (CRM) stock over the past year. The consensus rating of analytical firms is “Neutral”. The average analyst price target is $159,00 over the next 12 months. See the table below for the latest price targets and analyst forecasts for Salesforce Inc (CRM) shares.
Salesforce (CRM) Latest Price Targets
| Forecast date | Analytical firm | Change target price | Rating |
|---|---|---|---|
| 01/30/2023 | Morgan Stanley | $228→$236 | Overweight |
| 01/23/2023 | Deutsche Bank | $200→$190 | Buy |
| 01/18/2023 | DA Davidson | $150 | Neutral |
| 01/13/2023 | Atlantic Equities | $200→$140 | Neutral |
| 01/11/2023 | Bernstein | $134→$119 | Underperform |
| 01/09/2023 | Piper Sandler | $175→$171 | Overweight |
| 12/19/2022 | Morgan Stanley | $250→$228 | Overweight |
| 12/08/2022 | Baird | $200→$150 | Neutral |
| 12/05/2022 | Citigroup | $170→$164 | Neutral |
| 12/05/2022 | Citigroup | $170→$164 | Neutral |
| 12/05/2022 | Credit Suisse | $250→$225 | Outperform |
| 12/01/2022 | BMO Capital | $180→$172 | Outperform |
| 12/01/2022 | Mizuho | $225→$200 | Buy |
| 12/01/2022 | RBC Capital | $235→$200 | Outperform |
| 12/01/2022 | Deutsche Bank | $220→$200 | Buy |
| 12/01/2022 | Wells Fargo | $190→$175 | Overweight |
| 12/01/2022 | Wedbush | $215→$200 | Outperform |
| 12/01/2022 | Baird | $210→$200 | Outperform |
| 12/01/2022 | Cowen & Co. | $210→$195 | Outperform |
| 12/01/2022 | Atlantic Equities | $225→$200 | Overweight |
| 12/01/2022 | Truist Securities | $240→$210 | Buy |
| 12/01/2022 | UBS | $180→$162 | Neutral |
| 12/01/2022 | Canaccord Genuity | $215→$180 | Buy |
| 12/01/2022 | Raymond James | $225→$200 | Strong Buy |
| 12/01/2022 | B of A Securities | $210→$200 | Buy |
| 12/01/2022 | Oppenheimer | $200→$185 | Outperform |
| 12/01/2022 | Jefferies | $240→$230 | Buy |
| 06/02/2022 | Loop Capital | $225→$175 | Hold |
| 06/01/2022 | Stifel | $300→$250 | Buy |
| 06/01/2022 | Deutsche Bank | $300→$260 | Buy |
| 06/01/2022 | JP Morgan | $316→$275 | Overweight |
| 06/01/2022 | Baird | $300→$260 | Outperform |
| 06/01/2022 | Barclays | $208→$218 | Overweight |
| 06/01/2022 | Raymond James | $300→$250 | Strong Buy |
| 06/01/2022 | Wells Fargo | $225→$235 | Overweight |
| 06/01/2022 | BMO Capital | $260→$225 | Outperform |
| 06/01/2022 | Credit Suisse | $375→$315 | Outperform |
| 06/01/2022 | Piper Sandler | $330→$250 | Overweight |